ArticleJAMA neurology2023

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Tomas Kalincik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.